Our experts discuss the latest from Mayo Clinic Laboratories, so you can stay up to date on the most advanced diagnostics and newly developed tests. Note: Podcasts will not play back on Internet Explorer. Please use an alternative web...
Mitochondrial Disease [Test in Focus] - Insights
Linda Hasadsri, M.D., Ph.D., explains how Mayo Clinic Laboratories’ inclusive approach to mitochondrial disease testing expedites diagnosis. Using innovative methodologies like custom reagents and droplet digital PCR enables precision...
Carrier Screening [Test in Focus] - Insights
Michelle Kluge, M.S., CGC, explains how Mayo Clinic Laboratories’ CYPZ assay provides accurate testing for congenital adrenal hyperplasia. Using an in-depth methodology that incorporates Sanger sequencing, MCL can provide clear answers for...
Find out how our pediatric oncology testing was designed to deliver individualized insights to confirm diagnosis and guide treatment.
NGS Testing for Neuro-Oncology - Mayo Clinic Laboratories
Mayo Clinic is recognized worldwide for providing care for complex diseases including brain tumors. With rapid technological advancements and medical discoveries, the standard approach to genetic testing is evolving.
Myasthenia Gravis Testing - Mayo Clinic Laboratories
Our diagnostic algorithms consist of tests that are always performed, and then additional testing is performed depending on the initial results.
Learn how our testing identifies genetic and autoimmune causes of epilepsy. Accurate diagnosis helps physicians identify potential treatment options.
Neuro-Oncology Testing - Mayo Clinic Laboratories
At Mayo Clinic, we offer a comprehensive approach to neuro-oncology testing that focuses on the best outcomes for the patient
Testing for systemic lupus erythematosus (SLE) and related antiphospholipid syndrome (APS) at Mayo Clinic Laboratories is performed by experienced laboratory scientists and testing experts with decades of experience diagnosing autoimmune...
Dementia with Lewy bodies, Parkinson's, and multiple system atrophy - Insights
Learn more about how Mayo Clinic Laboratories' cerebrospinal fluid biomarker test for synucleinopathies, such as Parkinson’s disease and dementia with Lewy bodies, can accurately identify α-syn pathology even before definitive symptoms...